[Treatment of multiple sclerosis with natalizumab (Tysabri) in a setting of melanoma].
Schmutz
J-L
JL
Service de dermatologie, hôpital Fournier, 36 quai de la Bataille, Nancy cedex, France. jl.schmutz@chu-nancy.fr
Barbaud
A
A
Tréchot
P
P
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008545:Melanoma / Q000139:chemically induced* / Q000276:immunology; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab